These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 16075202)
1. A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy. Lucarini L; Giusti B; Zhang RZ; Pan TC; Jimenez-Mallebrera C; Mercuri E; Muntoni F; Pepe G; Chu ML Hum Genet; 2005 Sep; 117(5):460-6. PubMed ID: 16075202 [TBL] [Abstract][Full Text] [Related]
2. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Pan TC; Zhang RZ; Sudano DG; Marie SK; Bönnemann CG; Chu ML Am J Hum Genet; 2003 Aug; 73(2):355-69. PubMed ID: 12840783 [TBL] [Abstract][Full Text] [Related]
3. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy. Demir E; Sabatelli P; Allamand V; Ferreiro A; Moghadaszadeh B; Makrelouf M; Topaloglu H; Echenne B; Merlini L; Guicheney P Am J Hum Genet; 2002 Jun; 70(6):1446-58. PubMed ID: 11992252 [TBL] [Abstract][Full Text] [Related]
4. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Baker NL; Mörgelin M; Peat R; Goemans N; North KN; Bateman JF; Lamandé SR Hum Mol Genet; 2005 Jan; 14(2):279-93. PubMed ID: 15563506 [TBL] [Abstract][Full Text] [Related]
5. Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant. Zhang RZ; Zou Y; Pan TC; Markova D; Fertala A; Hu Y; Squarzoni S; Reed UC; Marie SKN; Bönnemann CG; Chu ML J Biol Chem; 2010 Mar; 285(13):10005-10015. PubMed ID: 20106987 [TBL] [Abstract][Full Text] [Related]
6. Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. Lampe AK; Zou Y; Sudano D; O'Brien KK; Hicks D; Laval SH; Charlton R; Jimenez-Mallebrera C; Zhang RZ; Finkel RS; Tennekoon G; Schreiber G; van der Knaap MS; Marks H; Straub V; Flanigan KM; Chu ML; Muntoni F; Bushby KM; Bönnemann CG Hum Mutat; 2008 Jun; 29(6):809-22. PubMed ID: 18366090 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of novel collagen VI non-canonical splicing mutations causing Ullrich congenital muscular dystrophy. Martoni E; Urciuolo A; Sabatelli P; Fabris M; Bovolenta M; Neri M; Grumati P; D'Amico A; Pane M; Mercuri E; Bertini E; Merlini L; Bonaldo P; Ferlini A; Gualandi F Hum Mutat; 2009 May; 30(5):E662-72. PubMed ID: 19309692 [TBL] [Abstract][Full Text] [Related]
8. Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies. Bovolenta M; Neri M; Martoni E; Urciuolo A; Sabatelli P; Fabris M; Grumati P; Mercuri E; Bertini E; Merlini L; Bonaldo P; Ferlini A; Gualandi F BMC Med Genet; 2010 Mar; 11():44. PubMed ID: 20302629 [TBL] [Abstract][Full Text] [Related]
10. Primary collagen VI deficiency is the second most common congenital muscular dystrophy in Japan. Okada M; Kawahara G; Noguchi S; Sugie K; Murayama K; Nonaka I; Hayashi YK; Nishino I Neurology; 2007 Sep; 69(10):1035-42. PubMed ID: 17785673 [TBL] [Abstract][Full Text] [Related]
11. COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy. Pepe G; Lucarini L; Zhang RZ; Pan TC; Giusti B; Quijano-Roy S; Gartioux C; Bushby KM; Guicheney P; Chu ML Ann Neurol; 2006 Jan; 59(1):190-5. PubMed ID: 16278855 [TBL] [Abstract][Full Text] [Related]
12. Aberrant mitochondria in a Bethlem myopathy patient with a homozygous amino acid substitution that destabilizes the collagen VI α2(VI) chain. Zamurs LK; Idoate MA; Hanssen E; Gomez-Ibañez A; Pastor P; Lamandé SR J Biol Chem; 2015 Feb; 290(7):4272-81. PubMed ID: 25533456 [TBL] [Abstract][Full Text] [Related]
13. Effects on collagen VI mRNA stability and microfibrillar assembly of three COL6A2 mutations in two families with Ullrich congenital muscular dystrophy. Zhang RZ; Sabatelli P; Pan TC; Squarzoni S; Mattioli E; Bertini E; Pepe G; Chu ML J Biol Chem; 2002 Nov; 277(46):43557-64. PubMed ID: 12218063 [TBL] [Abstract][Full Text] [Related]
14. Variable penetrance of COL6A1 null mutations: implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families. Peat RA; Baker NL; Jones KJ; North KN; Lamandé SR Neuromuscul Disord; 2007 Jul; 17(7):547-57. PubMed ID: 17537636 [TBL] [Abstract][Full Text] [Related]
15. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. Lampe AK; Dunn DM; von Niederhausern AC; Hamil C; Aoyagi A; Laval SH; Marie SK; Chu ML; Swoboda K; Muntoni F; Bonnemann CG; Flanigan KM; Bushby KM; Weiss RB J Med Genet; 2005 Feb; 42(2):108-20. PubMed ID: 15689448 [TBL] [Abstract][Full Text] [Related]